Maintains Outperform Rating
https://www.marketscreener.com/quote/stock/AMEDISYS-INC-8342/news/RBC-Cuts-Price-Target-on-Amedisys-to-139-From-165-After-Difficult-Q3-Maintains-Outperform-Ratin-42135800/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.